Medical Developments International Limited (Premium)



Ticker code: ASX:MYR

ASX:MYR Red Flags & Risk Indicators
⚠️ RED FLAGS: 3 identified

  • Increasing Shorts
  • Falling Earnings
  • More Net Debt Than Equity

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
3.92642 1.8986 1.95905 -51.6 3.2 0.43242 0.22158 0.27771 -48.8 25.3
ASX:MYR Revenue Per Share (2012–2027)
Medical Developments International Limited (ASX:MYR) Revenue Chart 2012–2027
ASX:MYR Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
Medical Developments International Limited (ASX:MYR) EBITDA Chart 2012–2027
ASX:MYR Normalised Earnings Per Share (EPS) (2012–2027)
Medical Developments International Limited (ASX:MYR) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
0.4 2.1 7.3 11.0 8.8 11.0 14.7 11.0 9/12/24
ASX:MYR Yearly Price Earnings Ratio (PER) Highs and Lows
Medical Developments International Limited (ASX:MYR) PER Highs and Lows (2012–2027)
ASX:MYR Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Medical Developments International Limited (ASX:MYR) 10-Year Weekly ATR Trailing Stop Price Chart


Leave a Reply

Your email address will not be published. Required fields are marked *